Skip to main content

Home/ Cancer/ Group items tagged tyrosine

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxyg... - 0 views

clincancerres.aacrjournals.org/...5930

2004 September study research in_vitro EGFR tyrosine_kinase inhibitors inhibitor inhibition TKI TKIs Iressa gefitinib COX-2 celecoxib Celebre3x Celebra head_and_neck_cancer head_and_neck cancer SCCHN SCC HNCA synergy medicine head neck oncology

shared by Matti Narkia on 15 Mar 09 - Cached
  • Matti Narkia on 15 Mar 09
     
    Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM. Clin Cancer Res. 2004 Sep 1;10(17):5930-9. PMID: 15355926
Matti Narkia

Ginkgo biloba extract EGb(R)761 exerts anti-angiogenic effects via activation of tyrosi... - 0 views

www.ncbi.nlm.nih.gov/...19175691

2008 October study research in_vitro Ginkgo_biloba Ginkgo extract EGb761 anti-angiogenesis anti-angiogenic cancer sodium_vanadate vanadium tyrosine_phosphatases nutrition herb herbs herbal_medicine medline

shared by Matti Narkia on 22 Feb 09 - No Cached
  • Matti Narkia on 22 Feb 09
     
    Ginkgo biloba extract EGb(R)761 exerts anti-angiogenic effects via activation of tyrosine phosphatases. Koltermann A, Liebl J, Fürst R, Ammer H, Vollmar AM, Zahler S. J Cell Mol Med. 2008 Oct 23. [Epub ahead of print] PMID: 19175691
Matti Narkia

Factors Associated With Clinical Benefit From Epidermal Growth Factor Receptor Inhibito... - 0 views

www.oncologystat.com/...noma_of_the_Head_and_Neck.html

2009 October oncologystat study review humans patients EGFR tyrosine kinase inhibitors TKI head_and_neck cancer head_and_neck_cancer hnca scchn recurrent metastatic advanced factors clinical benefits survival medline

shared by Matti Narkia on 08 Oct 09 - Cached
  • Matti Narkia on 08 Oct 09
     
    Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck. Cohen EE, Halpern AB, Kasza K, Kocherginsky M, Williams R, Vokes EE. Oral Oncol. 2009 Oct;45(10):e155-60. Epub 2009 Jul 7. PMID: 19586795
1 - 3 of 3
Showing 20▼ items per page